ArticleeNeurologicalSci2022

Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis.

Akira Hanazono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.